| Public health management of pertussis in adults: Practical challenges and future strategies CR MacIntyre, JC de Sousa, U Heininger, P Kardos, A Konstantopoulos, ... Human Vaccines & Immunotherapeutics 20 (1), 2377904, 2024 | | 2024 |
| Understanding the impact of adult pertussis and current approaches to vaccination: A narrative review and expert panel recommendations P Kardos, J Correia de Sousa, U Heininger, A Konstantopoulos, ... Human Vaccines & Immunotherapeutics 20 (1), 2324547, 2024 | 3 | 2024 |
| Biomarkers of tissue remodelling are elevated in serum of COVID-19 patients who develop interstitial lung disease-an exploratory biomarker study HW Breisnes, DJ Leeming, MA Karsdal, H Burke, A Freeman, T Wilkinson, ... BMC Pulmonary Medicine 24 (1), 331, 2024 | | 2024 |
| Dataset supporting the University of Southampton Doctoral Thesis" The role of non-typeable haemophilus influenzae biofilms in host-microbial and microbial-microbial … J Weeks, K Staples, T Wilkinson, CM Spalluto, K Ostridge University of Southampton, 2024 | | 2024 |
| Cytokine biomarkers of exacerbations in sputum from Chronic Obstructive Pulmonary Disease patients: a prospective cohort study S Budroni, M Taccone, M Stella, S Aprea, F Schiavetti, M Bardelli, ... The Journal of Infectious Diseases, jiae232, 2024 | | 2024 |
| Exacerbation predictive modelling using real-world data from the myCOPD app HMG Glyde, AM Blythin, TMA Wilkinson, IT Nabney, JW Dodd Heliyon 10 (10), 2024 | 5 | 2024 |
| Nebulised interferon beta-1a (SNG001) in the treatment of viral exacerbations of COPD PD Monk, JL Brookes, VJ Tear, TN Batten, C Newall, M Mankowski, ... Respiratory Research 25 (1), 228, 2024 | | 2024 |
| Structural predictors of lung function decline in young smokers with normal spirometry AI Ritchie, GC Donaldson, EA Hoffman, JP Allinson, CI Bloom, CE Bolton, ... American journal of respiratory and critical care medicine 209 (10), 1208-1218, 2024 | 7 | 2024 |
| Structural Predictors of Lung Function Decline in the British Early COPD Network (BEACON) Cohort AI Ritchie, EA Hoffman, JP Allinson, CI Bloom, CER Bolton, G Choudhury, ... C99. I CAN SEE THE FUTURE: NOVEL WAYS TO PREDICT COPD, A6653-A6653, 2024 | | 2024 |
| Characterization of Factors Associated With Disease Severity in Adults Hospitalized With Respiratory Viral Infection: The Universal Study TG Morelli, M Purcell, O Cox, P Lee, K Thorne, C Roberts, A Cazaly, ... C67. SCIENCE AND BEDSIDE BACTERIAL PNEUMONIA, A6245-A6245, 2024 | | 2024 |
| Burden of Uncontrolled Severe Asthma With and Without Elevated Type-2 Inflammatory Biomarkers B Ding, S Chen, E Rapsomaniki, A Quinton, W Cook, HK Reddel, A Papi, ... The Journal of Allergy and Clinical Immunology: In Practice 12 (4), 970-982, 2024 | | 2024 |
| Characterising user engagement with mHealth for chronic disease self-management and impact on machine learning performance C Duckworth, B Cliffe, B Pickering, B Ainsworth, A Blythin, A Kirk, ... npj Digital Medicine 7 (1), 66, 2024 | | 2024 |
| Exploring the Validity of GOLD 2023 Guidelines: Should GOLD C and D Be Combined? C Duckworth, MJ Boniface, A Kirk, TMA Wilkinson International Journal of Chronic Obstructive Pulmonary Disease, 2335-2339, 2023 | 1 | 2023 |
| Estimating the health and economic impact of improved management in prevalent chronic obstructive pulmonary disease populations in England, Germany, Canada, and Japan: a … EJ Adams, A van Doornewaard, Y Ma, N Ahmed, MK Cheng, H Watz, ... International Journal of Chronic Obstructive Pulmonary Disease, 2127-2146, 2023 | 2 | 2023 |
| Feasibility of home administration of nebulised interferon ß-1a (SNG001) for COVID-19: a remote study NA Francis, PD Monk, J Nuttall, T Oliver, C Simpson, JL Brookes, VJ Tear, ... BJGP open 7 (4), 2023 | | 2023 |
| 375. The Effect of Inhaled Interferon Beta-1a (SNG001) Treatment Compared to Placebo on Lung Antiviral Biomarkers and Viral Clearance in Chronic Obstructive Pulmonary Disease … PD Monk, JL Brookes, VJ Tear, T Batten, C Newall, M Mankowski, ... Open Forum Infectious Diseases 10 (Supplement_2), ofad500. 445, 2023 | | 2023 |
| S108 Biological predictors of severity in respiratory viral infection (RVI): preliminary data from UNIVERSAL, a multicentre prospective observational study T Morelli, M Purcell, A Kong, B Welham, C Roberts, A Allen, N Scott, ... Thorax 78 (Suppl 4), A77-A78, 2023 | | 2023 |
| P235 A point prevalence study of COPD therapy in 13361 patients using the myCOPD app: examining real-time capture of disease control measures S Bourne, J El-Khoury, A Veldman, T Wilkinson Thorax 78 (Suppl 4), A254-A255, 2023 | | 2023 |
| USE OF INHALED INTERFERON-BETA TO IMPROVE OUTCOME IN SARS-CoV-2 INFECTED PATIENTS R Marsden, M Phillip, T Wilkinson US Patent App. 18/016,964, 2023 | | 2023 |
| Treating acute exacerbations of COPD with Chinese herbal medicine to aid antibiotic use reduction (Excalibur): a randomised double-blind, placebo-controlled feasibility trial ML Willcox, XY Hu, T Oliver, K Thorne, C Boxall, G He, C Simpson, ... Frontiers in Pharmacology 14, 1221905, 2023 | 2 | 2023 |
Karl J StaplesProfessor of Respiratory Immunology & Pharmacology在 port.ac.uk 的电子邮件经过验证
